ALPMY
ASTELLAS PHARMA/ADR

310
Mkt Cap
$23.43B
Volume
288,657.00
52W High
$13.69
52W Low
$8.37
PE Ratio
27.20
ALPMY Fundamentals
Price
$13.08
Prev Close
$13.21
Open
$13.69
50D MA
$11.60
Beta
0.26
Avg. Volume
87,397.37
EPS (Annual)
$0.1859
P/B
2.15
Rev/Employee
$919,438.95
Loading...
Loading...
News
all
press releases
Japan’s Astellas Pharma hits 8-mth high on upbeat Q1 earnings
Investing.com-- Shares of Astellas Pharma Inc. (TYO:4503) jumped to an eight-month high on Thursday after the Japanese drugmaker reported robust first-quarter earnings, driven by strong sales of key cancer treatments and cost-cutting measures.
investing.com·5mo ago
News Placeholder
More News
News Placeholder
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Here is how Abbott (ABT) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
Zacks·5mo ago
News Placeholder
Is Alpha Cognition Inc. (ACOG) Outperforming Other Medical Stocks This Year?
Here is how Alpha Cognition Inc. (ACOG) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
Zacks·5mo ago
News Placeholder
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
Zacks·6mo ago
News Placeholder
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
Zacks·7mo ago
News Placeholder
Here's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock Now
Zacks·7mo ago

Latest ALPMY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.